By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Iovance Biothereapeutics, Inc. (Formerly Known As Lion Biotechnologies, Inc.) 

999 Skyway Road
Suite 150
San Carlos  California  94070  U.S.A.
Phone: 650-260-7120 Fax: n/a


Company News
Iovance Biotherapeutics Announces Pricing Of Its Public Offering Of $50 Million Of Common Stock 9/21/2017 10:32:04 AM
Iovance Biotherapeutics Announces Public Offering Of Common Stock 9/20/2017 8:24:41 AM
Iovance Biotherapeutics Announces Approval Of First Clinical Trial Application By Competent Authority In Netherlands For A Phase II Trial Of LN-145 For The Treatment Of Patients With Cervical Cancer 9/13/2017 6:53:35 AM
Iovance Biotherapeutics Partners With TrakCel For Personalized Patient Product Management 9/11/2017 11:17:24 AM
Iovance Biotherapeutics Enters Into A Research Collaboration Focused On Hematologic Malignancies With The Ohio State University Comprehensive Cancer Center 9/7/2017 10:34:50 AM
CEO of Bay Area’s Iovance Biotherapeutics Sees TIL Technology as Best Immunotherapy Option for Treating Solid Tumors 9/6/2017 10:59:12 AM
Iovance Biotherapeutics Announces FDA Fast Track Designation For LN-144 For Treatment Of Advanced Melanoma 9/1/2017 8:20:04 AM
Iovance Biotherapeutics Announces First Patient Dosed In C-145-04 Phase II Trial In Cervical Cancer 8/16/2017 7:04:38 AM
Iovance Biotherapeutics Appoints Timothy Morris As Chief Financial Officer 8/9/2017 11:40:58 AM
Iovance Biotherapeutics Reports Second Quarter 2017 Financial Results 8/2/2017 1:42:20 PM